| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.28 | 5e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.25 | 9e-06 |